Posts by tag
CancerWorld
Protecting Europe’s Cancer Care Model in a Changing World
Key discussions and priorities from the 2026 Cancer Patients Europe Annual Meeting As Europe faces growing pressure on its healthcare systems, Cancer Patients Europe (CPE) brought together patient representatives, policymakers, clinicians, researchers, and industry leaders in Brussels from 24 to…
The Cost of Silence Has Been Death
After surviving cervical cancer at 25, Tamika Felder transformed personal tragedy into a global movement. In this CancerWorld interview, she reflects on fear, stigma, infertility, survivorship, advocacy, and why the world already has everything it needs to eliminate one of…
Sixteen Years Clear, Then it Came Back: A Husband’s Reckoning with Cancer, Faith, and the Ordinary Courage of Carrying On
For sixteen years, cancer became something we spoke about in the past tense. My wife, Lynn, had survived a rare smooth-muscle cancer (leiomyosarcoma) after two operations in 2009. Year after year the scans came back clear. Gradually, we stopped living…
In Memoriam: Dr Mary Buchanan (1929–2026)
The European cancer community has lost one of its most influential voices for breast cancer advocacy. Dr. Mary Buchanan—physician, advocate, and one of the founding figures of Europa Donna – The European Breast Cancer Coalition—passed away on 18 June 2026.…
Oncology Couch: Questions, Answers, and the Space in Between
To patients and oncologists alike: Are there questions living inside you that you have not been asking out loud? Could it be that you do not even know what questions to ask? Are there answers you have arrived at privately…
Gloria Okwu: Turning Pain into Purpose
When Gloria Chiniere Okwu discovered a lump in her left breast in 2016, she could not have imagined that the diagnosis would eventually make her one of the most influential patient advocates in Nigeria. Today, Gloria is a cancer survivor,…
Finding Her Voice: How One Little Girl’s Loss Became a Lifelong Lesson in Listening
When Martha Raymond, the Founder and CEO of the GI Cancers Alliance and the Raymond Foundation, was seven years old, she lost her father to colon cancer. Years later, her mother's illness would change the course of her own life.…
CancerWorld #118 (August 2026)
We often describe progress in oncology through the language of discovery. Scientific breakthroughs. Technological innovation. Deeper biological insight. These advances have transformed medicine, helping millions of people live longer and better than ever before. Yet alongside every scientific breakthrough, a…
Could GLP-1 Drugs Slow Cancer Spread? New Study Offers Encouraging Clues
Treatment with GLP-1 receptor agonists (GLP-1RAs) was associated with a significantly lower risk of progression to metastatic disease in non–small cell lung cancer (NSCLC), breast cancer, colorectal cancer (CRC), and hepatocellular carcinoma (HCC). The study, presented at the 2026 American…
Behind Every Drug There Is a Story: Brian Druker, Imatinib, and the Human Journey Behind a Revolution in Cancer Care
Twenty-five years after imatinib transformed chronic myeloid leukaemia from a fatal diagnosis into a manageable disease for many patients, Brian Druker reflects on the curiosity, setbacks, and patients who shaped one of oncology's greatest breakthroughs. Long before I understood the…